...
机译:P-选择素拮抗剂Heldacumab对非ST段抬高后经皮冠状动脉介入后心肌损伤的影响:选择 - ACS试验的结果
Montreal Heart Institute Université de Montréal 5000 Belanger Street Montreal QC H1T 1C8 Canada;
Montreal Heart Institute Université de Montréal 5000 Belanger Street Montreal QC H1T 1C8 Canada;
Mayo Clinic Rochester MN United States;
Montreal Heart Institute Université de Montréal 5000 Belanger Street Montreal QC H1T 1C8 Canada;
Montreal Heart Institute Université de Montréal 5000 Belanger Street Montreal QC H1T 1C8 Canada;
Montreal Heart Institute Université de Montréal 5000 Belanger Street Montreal QC H1T 1C8 Canada;
Montreal Heart Institute Université de Montréal 5000 Belanger Street Montreal QC H1T 1C8 Canada;
Montreal Heart Institute Coordinating Center (MHICC) Montreal QC Canada;
Hoffmann-La Roche Basel Switzerland;
Institut Universitaire de Cardiologie et de Pneumologie de Québec Quebec City QC Canada;
Montreal Heart Institute Coordinating Center (MHICC) Montreal QC Canada;
Montreal Heart Institute Coordinating Center (MHICC) Montreal QC Canada;
Hoffmann-La Roche Basel Switzerland;
Montreal Heart Institute Coordinating Center (MHICC) Montreal QC Canada;
Montreal Heart Institute Université de Montréal 5000 Belanger Street Montreal QC H1T 1C8 Canada;
inclacumab; myocardial infarction; P-selectin; percutaneous coronary intervention;
机译:P-选择素拮抗剂Inclacumab对经皮冠状动脉介入治疗非ST段抬高型心肌梗死后心肌损伤的影响:SELECT-ACS试验结果(第61卷,第2048页,2013年)
机译:P-选择素拮抗剂Heldacumab对非ST段抬高后经皮冠状动脉介入后心肌损伤的影响:选择 - ACS试验的结果
机译:P-选择素拮抗剂Inclacumab对非段抬高型心肌梗死经皮冠状动脉介入治疗后心肌损伤的影响:SELECT-ACS试验结果
机译:肾功能不全对初级经皮冠状动脉干预治疗的ST段升高心肌梗死患者30天后的影响
机译:荟萃分析:与标准PCI相比,ST抬高型心肌梗死患者在PCI(经皮冠状动脉介入治疗)期间进行血栓切除术对死亡率,再梗塞和靶血管血运重建的影响。
机译:P-Selectin拮抗剂Inclacumab对根据输注时间经皮冠状动脉介入治疗后心肌损伤的影响:SELECT-ACS试验的启示
机译:P-Selectin拮抗剂Inclacumab对SELECT-ACS试验非ST段抬高型心肌梗死经皮冠状动脉介入治疗后心肌损伤的影响